Pertuzumab biosimilar
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pertuzumab biosimilar, covering 2025-08-06 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease